AVIR logo
Atea Pharmaceuticals, Inc.(AVIR)
Last print unknown agoAbout this dataData status
$4.39▲0.07 (1.62%)Stale · unknown old

AVIR R&D Expenses

$155.45MTTM · USD

Period ending:

AVIR FY R&D ExpensesUSD
AVIR FY R&D Expenses2018-12-31: $6.68M2019-12-31: $10.17M2020-12-31: $38.02M2021-12-31: $167.21M2022-12-31: $88.84M2023-12-31: $132.84M2024-12-31: $145.40M2025-12-31: $148.02M$167.21M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AVIR r&d expenses history

Research and development spending. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Atea Pharmaceuticals Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
148,024,000
145,401,000
132,843,000
88,836,000
167,205,000
38,023,000
10,170,000
6,675,000

Compare r&d expenses

All AVIR financial metrics · AVIR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.